Clinical Trial

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

Name: Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. — clinical trial record (NCT04904146)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BIO-MUSE

Recruiting

View on ClinicalTrials.gov →

Summary

A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2021-05-21.

Trial Details

NCT Number	NCT04904146
Lead Sponsor	Lund University Hospital
Conditions	Mycosis Fungoides, Sezary Syndrome
Enrollment	120 participants
Start Date	2021-04-02
Primary Completion	2027-04 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2025-03-10